福安药业：预计2025年净利润同比下降64.26%-74.99%

Core Viewpoint - The company, Fu'an Pharmaceutical, anticipates a significant decline in net profit for the fiscal year 2025, projecting a range of 70 million to 100 million yuan, which represents a year-on-year decrease of 64.26% to 74.99% due to the implementation of national drug procurement policies leading to substantial price reductions of its main products [1] Financial Performance - The expected net profit for 2025 is estimated to be between 70 million and 100 million yuan [1] - This projection indicates a decline of 64.26% to 74.99% compared to the previous year [1] Market Conditions - The implementation of national drug procurement is causing a significant drop in sales prices of the company's main products [1] - As a result, the company's operating revenue is decreasing, leading to continued pressure on profit margins [1]